14 results
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
, 2020 – Neurotrope, Inc. (Nasdaq: NTRP) and Metuchen Pharmaceuticals, L.L.C., a privately held biopharmaceutical company focused on innovative … ”), as well as pursue innovative treatment options in other high-value disease areas.”
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, PC served as legal
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
26 Apr 22
Other Events
4:30pm
Commercial Officer. “This relationship with the Wellman Center at Mass General has the potential to empower the male patient with innovative … , and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
13 Jul 23
Petros Pharmaceuticals Announces Capital Raise of $15 million
4:41pm
to several prescription medications and enable innovative tools to help support the switch process.
About STENDRA® (avanafil)
Stendra® (avanafil … , acquiring, and commercializing innovative therapeutics for men's health issues, including, but not limited to, erectile dysfunction, endothelial dysfunction
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
28 Jul 22
Other Events
11:26am
by identifying, developing, acquiring, and commercializing innovative therapeutics for men’s health issues including, but not limited to erectile
8-K
EX-99.1
PTPI
Petros Pharmaceuticals Inc
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual
8-K
EX-99.1
gx50x12fa 5pv2p0j2
27 Dec 21
Petros Pharmaceuticals Announces $7.5 Million Offering
5:02pm
8-K
EX-99.1
kn86iw1e 51qpvousr0v
1 Dec 21
Petros Pharmaceuticals Announces $10 Million Offering
5:12pm
8-K
EX-99.1
18kdk19
30 Nov 22
Petros Pharmaceuticals Announces Reverse Stock Split
4:05pm
8-K
EX-99.1
yxschxgrst2 9j
16 Nov 21
Petros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
12:00am
8-K
EX-99.1
cdjj0kua
4 Apr 22
Petros Pharmaceuticals Reports Year End 2021 Financial Results and Corporate Highlights
4:15pm
8-K
EX-99.1
hyki 0e0k8
15 Nov 22
Petros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Corporate Update
8:30am
8-K
EX-99.1
t6pcfl
15 Aug 22
Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022
9:16am
- Prev
- 1
- Next